Analysts Set BWX Technologies, Inc. (NYSE:BWXT) Price Target at $199.20

BWX Technologies, Inc. (NYSE:BWXT) has received an average rating of “Moderate Buy” from the thirteen brokerages that are covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and three have assigned a strong buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $199.20.

A number of analysts have commented on the company. Weiss Ratings cut BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 26th. Truist Financial set a $205.00 target price on shares of BWX Technologies in a report on Friday, January 9th. Wall Street Zen raised shares of BWX Technologies from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. BNP Paribas Exane started coverage on shares of BWX Technologies in a research report on Thursday, January 15th. They issued a “neutral” rating and a $215.00 price target for the company. Finally, Northland Securities set a $225.00 price objective on shares of BWX Technologies in a research report on Tuesday, November 4th.

BWX Technologies Trading Up 1.7%

Shares of BWXT stock opened at $200.31 on Friday. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.71 and a quick ratio of 1.62. The company has a market cap of $18.31 billion, a price-to-earnings ratio of 60.15, a PEG ratio of 3.22 and a beta of 0.83. BWX Technologies has a 1 year low of $84.21 and a 1 year high of $220.57. The firm has a fifty day moving average price of $193.08 and a 200-day moving average price of $185.57.

Insiders Place Their Bets

In related news, CEO Rex D. Geveden sold 10,000 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $203.26, for a total transaction of $2,032,600.00. Following the completion of the transaction, the chief executive officer directly owned 177,594 shares of the company’s stock, valued at approximately $36,097,756.44. This represents a 5.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.47% of the company’s stock.

Hedge Funds Weigh In On BWX Technologies

Institutional investors have recently bought and sold shares of the business. Wedbush Securities Inc. increased its holdings in shares of BWX Technologies by 4.3% in the 4th quarter. Wedbush Securities Inc. now owns 1,263 shares of the technology company’s stock worth $218,000 after buying an additional 52 shares during the last quarter. Oppenheimer Asset Management Inc. increased its stake in BWX Technologies by 1.0% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 5,448 shares of the technology company’s stock worth $942,000 after acquiring an additional 54 shares during the last quarter. Stratos Wealth Partners LTD. increased its stake in BWX Technologies by 3.5% during the fourth quarter. Stratos Wealth Partners LTD. now owns 1,979 shares of the technology company’s stock worth $342,000 after acquiring an additional 67 shares during the last quarter. Corient Private Wealth LLC raised its position in BWX Technologies by 1.2% during the second quarter. Corient Private Wealth LLC now owns 5,880 shares of the technology company’s stock valued at $847,000 after purchasing an additional 69 shares during the period. Finally, HHM Wealth Advisors LLC lifted its stake in shares of BWX Technologies by 17.9% in the 2nd quarter. HHM Wealth Advisors LLC now owns 460 shares of the technology company’s stock valued at $66,000 after purchasing an additional 70 shares during the last quarter. Institutional investors own 94.39% of the company’s stock.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.